Improving DNA vaccine delivery
Nature Technology has launched an improved delivery technology for
DNA vaccines that is now available for license by companies working
in this fast-growing area
ICOS gets manufacturing contract from Lilly
ICOS has entered into a biologics manufacturing agreement with Eli
Lilly, in which the Bothell, Washington-based firm will manufacture
two clinical candidates
Pharma firms risking fines for manufacturing neglect
Pharmaceutical company mergers and acquisitions plus industry-wide
cost cutting has squeezed investment into manufacturing, which may
lead to GMP non-compliance and fines, warns a new report.
Patheon Italia signs new deal with Roche
Patheon Italia has extended its manufacturing services agreement
with Roche to continue to supply the Swiss firm with solid, liquid
and sterile products for the European market.
Oligo licence for Transgenomic
Transgenomic has taken out a non-exclusive licence from Geron in
which it gains manufacturing rights to phosphoramidate and
Fall-out hits GSK after AGM 'fat cat' revolt
Two members of GlaxoSmithKline's remuneration committee have
resigned in the wake of the company's defeat by shareholders over
its pay policy.
US patent for pressure-sensitive reaction system
Boston Biomedica has been issued an additional US patent covering
the design and use of its Pressure Cycling Technology for the
control of pressure-sensitive chemical reactions.
EU clinical trials regs could damage uk
The UK BioIndustry Association has serious concerns that the EU
Clinical Trials Directive could have a negative impact on the
attractiveness of the UK as a location for clinical research.
West extends ready-to-sterilise service to Europe, Asia
West Pharmaceutical Services is rolling out its Westar RS
sterilized component service, formerly only available from its US
facilities, at sites in France, Germany and Singapore.
Schering-Plough cuts deal with FDA on production
Schering-Plough has reached an agreement with the US Food and Drug
Administration to correct the firm's manufacturing compliance
problems, which led to a $500 million fine last year.
Xenova to make cancer vaccine for Pharmexa
Xenova of the UK has been awarded a two-year contract by Sweden's
Pharmexa for the manufacture of a vaccine in clinical trials as a
treatment for breast cancer and other tumours.
'Biobucks' make a return as Schroder raises $402m
Schroder Ventures Life Sciences has raised $402 million (€344m) for
its biotechnology investment fund, providing a signal that venture
capital may at last be turning its head back in the direction of
New science chief at METabolic EXplorer
METabolic EXplorer, a French biotechnology company specialising in
the development and production of new biological processes for the
manufacturing of chemicals and pharmaceuticals, has bolstered its
scientific team with the appointment...
CLL Biopharma bought by US firm
France's CLL Pharma, a specialist in drug reformulations and novel
delivery technologies, has been acquired by US company Neuro
Baxter to invest $100m in parenterals plant
Baxter Healthcare of the US says it is planning a seven-year, $100
million (€85m) expansion of its parenteral contract manufacturing
services for pharma and biotech companies.